Oncolytics Biotech Inc.
Oncolytics Biotech Inc. is focused on the development of oncolytic viruses as a novel and effective approach to cancer treatment. Oncolytics’ lead product, REOLYSIN, is developed from the human reovirus.
Market Data
Contacts & RSS
Investor Relations
Erika Moran
Public Relations
Janet Vasquez
Phone
212.825.3210
